Manabat, Cristuto B.
HRN: 23-67-39 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/11/2023
CEFTAZIDIME 1GM (VIAL)
11/11/2023
11/17/2023
IV
1gm
Q8
Cap Mr: Massive Pleural Effusion Left
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes